OR WAIT null SECS
March 27, 2019
Valitacell, Solentim, and Microcoat were awarded EUR 3.5 million (US$4 million) to produce an integrated platform to deposit, culture, profile, and select optimal cells for biologic drug manufacturing.
Worth up to $605 million, the collaboration will focus on studying a preclinical novel target that could lead to potential new treatments for autoimmune diseases.
March 22, 2019
PDC*line Pharma has entered into a licensing agreement with LG Chem to develop a lung cancer vaccine in Asia.
Cell Mogrify (Mogrify), has been granted funding by the UK’s innovation agency, Innovate UK, to accelerate regenerative cell therapies.
March 20, 2019
The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.
March 14, 2019
Stream Bio entered into a new agreement with DBA Italia to launch Stream Bio’s nanotech-based bioimaging probes in Italy.
March 12, 2019
The companies will join forces to improve gene- and cell-therapy manufacturing using the cloud and machine learning.
The acquisition of the site in Copenhagen, Denmark, will significantly expand Fujifilm’s capacity and capabilities.
March 08, 2019
Swedish based company, SenzaGen, has signed a license agreement with contract research organization (CRO) MB Research Labs.
Iksuda Therapeutics and Femtogenix, have signed a license agreement aimed at progressing Iksuda’s lead ADC to clinic, with the aim of targeting difficult-to-treat solid tumors.